M05.9

Seropositive rheumatoid arthritis confirmed by positive rheumatoid factor but with no further specification of joint site, laterality, or systemic organ involvement.

Verified May 8, 2026 · 7 sources ↓

Status: Billable
Chapter: 13
Related CPT: 11
Region: Multi-region

Drawn from CDCICD10DataAAPCUnboundmedicineHealthcareinspiredllc

Documentation tips

What should appear in the chart to support M05.9.

Source · Editorial brief grounded in 7 cited references ↓

Name the specific joints affected (e.g., bilateral MCP joints, left wrist, right knee) so the coder can move from M05.9 to a site-specific M05.7xx or M05.8xx code.
Record the rheumatoid factor result explicitly — test name, lab value, and positive/negative status — to justify placement in M05 (seropositive) rather than M06 (seronegative).
If systemic complications are present (pulmonary nodules, vasculitis, pericarditis, peripheral neuropathy), document them by name so the appropriate M05.1–M05.6 subcategory can be applied instead of M05.9.
On chronic problem lists, revisit M05.9 at each encounter and update to a site-specific code once joint-level examination or imaging findings are documented.
Document functional impact (grip strength, ROM limitations, ADL restrictions) to support medical necessity for DMARDs, biologic infusions, or joint procedures billed alongside M05.9.

Related CPT procedures

Procedure codes commonly billed with M05.9. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

99213 $95.19

Established patient office or outpatient visit requiring 20–29 minutes of total time or low-complexity medical decision-making.

99214 $135.61

Office visit for an established patient requiring moderate-complexity medical decision making (MDM), or 30–39 minutes of total provider time on the date of service.

99215 $192.39

Highest-level office or outpatient E/M visit for an established patient, qualifying via high-complexity medical decision making or 40–54 minutes of total provider time on the date of service.

20610 $68.81

Aspiration and/or injection of a major joint or bursa (shoulder, hip, knee, or subacromial bursa) performed without ultrasound guidance.

20611 $104.21

Aspiration or injection of a major joint or bursa performed under real-time ultrasound guidance, with permanent image documentation.

96372 $15.36

Administration of a drug by injection under the skin or into a muscle for treatment, prevention, or diagnosis, with the drug itself billed separately.

86431 $0.00

Lab test that measures the amount of rheumatoid factor in a blood sample, reported as a numeric value rather than a simple positive or negative result.

86140 $0.00

Measurement of C-reactive protein, an acute phase marker that rises quickly with infection or inflammation and falls as it resolves.

J0129 $0.00

HCPCS drug code for abatacept given by injection or infusion in a clinic, billed in 10 mg units, used mostly for rheumatoid arthritis.

J1602 $0.00

HCPCS drug code for golimumab given by IV infusion in a clinic, billed per 1 mg, used for rheumatoid and psoriatic arthritis and ankylosing spondylitis.

J1745 $0.00

HCPCS drug code for brand infliximab (the reference product, not a biosimilar) given by IV infusion, billed per 10 mg.

Common coding pitfalls

The recurring mistakes coders make with M05.9 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

Using M05.9 permanently when the note clearly names affected joints — drop to M05.711–M05.79x (without organ involvement) or M05.811–M05.89 (other RA with RF) once site is documented.
Confusing M05.9 (seropositive, unspecified) with M06.00 (seronegative, unspecified site) — the distinction depends on whether rheumatoid factor was documented as positive; a missing RF result defaults to M06, not M05.
Failing to code systemic manifestations separately: if RA-associated Felty's syndrome, rheumatoid lung disease, or vasculitis is documented, M05.0–M05.6 subcategories are required, not M05.9.
Pairing M05.9 with symptom codes (joint pain, swelling) that are integral to RA — those are included in the M05.9 code and should not be coded additionally per ICD-10-CM convention.
Assigning M05.9 for juvenile RA: the category M05 explicitly excludes juvenile rheumatoid arthritis (M08.-); for patients under 16, use M08 codes.

Clinical context

Source · Editorial summary grounded in 7 cited references ↓

M05.9 is the default landing code when a provider documents rheumatoid arthritis with a positive rheumatoid factor (seropositive RA) but does not specify which joint(s) are affected or whether systemic complications are present. It sits at the bottom of the M05 hierarchy — use it only when the note genuinely lacks site and involvement detail, not as a shortcut to avoid the more granular codes.

The M05 category has extensive subcategory structure. If the chart documents organ involvement (lung: M05.1, vasculitis: M05.2, heart: M05.3, myopathy: M05.4, polyneuropathy: M05.5), use the appropriate subcategory. If there is no organ involvement, M05.7xx with a site-specific 6th character is the correct target. M05.9 is reserved for situations where the documentation is genuinely silent on site and involvement — an initial visit note, a consult with incomplete workup, or an outside record transfer where specifics haven't been captured yet.

For HCC risk-adjustment purposes (CMS-HCC V24, V28, RX-HCC V08), seropositive RA codes under M05 carry HCC weight. Specificity matters: payers and auditors expect M05.9 to be updated to a site-specific code once the clinical record supports it. Leaving M05.9 permanently on a chronic problem list when joint-level documentation exists is an audit flag.

Sibling codes

Other billable codes under M05 (laterality / anatomic variants).

M05.A

Abn rheu fctr & anti-citrul protein antibody w rheu arthrit

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 7 cited references ↓

01When is M05.9 appropriate versus a more specific M05 code?

M05.9 is appropriate only when the documentation confirms seropositive RA (positive RF) but is genuinely silent on which joints are affected and whether systemic organs are involved. Once the note names a joint or documents organ involvement, move to the corresponding site-specific or complication subcategory.

02What is the difference between M05.9 and M06.9?

M05.9 requires documented positive rheumatoid factor (seropositive RA, unspecified site). M06.9 is used when RA is present but rheumatoid factor is absent or not documented (seronegative or unspecified type). If the RF result is missing from the record, default to M06, not M05.

03Does M05.9 map to an HCC risk-adjustment category?

Yes. Seropositive RA codes under M05, including M05.9, map to HCC categories in CMS-HCC V24, V28, and RX-HCC V08 models. Specificity within M05 does not change the HCC assignment, but accurate placement in M05 versus M06 does affect risk scoring — confirm RF documentation before assigning M05.9.

04Can M05.9 be used for a patient with both RA and Felty's syndrome?

No. Felty's syndrome (splenomegaly and neutropenia complicating seropositive RA) has its own subcategory, M05.0x, with site-specific 6th characters. Use M05.0x, not M05.9, when Felty's is documented.

05What CPT codes are commonly billed alongside M05.9?

Office evaluation and management codes (99213–99215) for ongoing RA management, 20610 or 20611 for joint aspiration/injection, 86431 for rheumatoid factor testing, 96372 for subcutaneous biologic injections, and HCPCS J-codes such as J0129 (abatacept), J1602 (golimumab), and J1745 (infliximab) for biologic therapy administration.

06Can M05.9 be used for juvenile rheumatoid arthritis?

No. Category M05 explicitly excludes juvenile rheumatoid arthritis. For patients under 16 with inflammatory arthritis, use codes from the M08 category.

07Should symptom codes like joint pain or swelling be coded alongside M05.9?

No. Joint pain, swelling, and stiffness are integral manifestations of rheumatoid arthritis and are included in M05.9 per ICD-10-CM convention. Do not add M25.5xx (joint pain) or similar symptom codes when M05.9 is already established as the definitive diagnosis.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

Mira Scribe

Mira's AI scribe captures positive rheumatoid factor status, the specific joints examined, any documented systemic involvement (pulmonary, cardiac, vascular, neurologic), and current DMARD or biologic therapy from the encounter note. That detail lets the coder place the diagnosis in the correct M05 subcategory rather than defaulting to M05.9, preventing HCC undercapture and audit exposure from chronic use of an unspecified code.

See how Mira captures M05.9 documentation